ACE2, Much More Than Just a Receptor for SARS-COV-2
Overview
Infectious Diseases
Microbiology
Authors
Affiliations
The rapidly evolving pandemic of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection worldwide cost many lives. The angiotensin converting enzyme-2 (ACE-2) has been identified as the receptor for the SARS-CoV-2 viral entry. As such, it is now receiving renewed attention as a potential target for anti-viral therapeutics. We review the physiological functions of ACE2 in the cardiovascular system and the lungs, and how the activation of ACE2/MAS/G protein coupled receptor contributes in reducing acute injury and inhibiting fibrogenesis of the lungs and protecting the cardiovascular system. In this perspective, we predominantly focus on the impact of SARS-CoV-2 infection on ACE2 and dysregulation of the protective effect of ACE2/MAS/G protein pathway vs. the deleterious effect of Renin/Angiotensin/Aldosterone. We discuss the potential effect of invasion of SARS-CoV-2 on the function of ACE2 and the loss of the protective effect of the ACE2/MAS pathway in alveolar epithelial cells and how this may amplify systemic deleterious effect of renin-angiotensin aldosterone system (RAS) in the host. Furthermore, we speculate the potential of exploiting the modulation of ACE2/MAS pathway as a natural protection of lung injury by modulation of ACE2/MAS axis or by developing targeted drugs to inhibit proteases required for viral entry.
Al-Momani H, Nelson A, Al Balawi H, Al Balawi D, Aolymat I, Khasawneh A Sci Rep. 2025; 15(1):1811.
PMID: 39805887 PMC: 11730684. DOI: 10.1038/s41598-025-85806-5.
Zhou L, Zhang L, Xu F BMC Infect Dis. 2025; 25(1):29.
PMID: 39762748 PMC: 11702273. DOI: 10.1186/s12879-024-10364-6.
Antiviral activity of an ACE2-Fc fusion protein against SARS-CoV-2 and its variants.
Bermudez-Abreut E, Fundora-Barrios T, Hernandez Fernandez D, Noa Romero E, Fraga-Quintero A, Casadesus Pazos A PLoS One. 2025; 20(1):e0312402.
PMID: 39752453 PMC: 11698409. DOI: 10.1371/journal.pone.0312402.
Docking heparan sulfate-based ligands as a promising inhibitor for SARS-CoV-2.
Benicio L, Nascimento E, Martins J J Mol Model. 2024; 31(1):19.
PMID: 39666205 DOI: 10.1007/s00894-024-06236-0.
Potential Beneficial Role of Nitric Oxide in SARS-CoV-2 Infection: Beyond Spike-Binding Inhibition.
Sanchez-Garcia S, Castrillo A, Bosca L, Prieto P Antioxidants (Basel). 2024; 13(11).
PMID: 39594443 PMC: 11591382. DOI: 10.3390/antiox13111301.